- Urinary chitinase 3-like 1 and intestinal fatty-acid binding proteins are not elevated in children with inflammatory bowel disease
-
Ho SSC, Keenan JI, Day AS
- KMID: 2535825
- Intest Res.
- 2022 Oct;20(4):509-513.
- doi: 10.5217/ir.2022.00064
-
- CITED
-
- Close
- SHARE
-
- Close
- Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education
-
Kim S, Koh SJ
- KMID: 2535814
- Intest Res.
- 2022 Oct;20(4):389-391.
- doi: 10.5217/ir.2022.00117
-
- CITED
-
- Close
- SHARE
-
- Close
- Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies
-
Lima PA, Berg BB, Castor MGMe
- KMID: 2535815
- Intest Res.
- 2022 Oct;20(4):392-417.
- doi: 10.5217/ir.2021.00160
The components of the endogenous cannabinoid system are widely expressed in the gastrointestinal tract contributing to local homeostasis. In general, cannabinoids exert inhibitory actions in the gastrointestinal tract, inducing anti-inflammatory,... -
- CITED
-
- Close
- SHARE
-
- Close
- Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
-
Barnes A, Carter D, Kaazan P, Walsh A, Connor S, Andrews JM
- KMID: 2535824
- Intest Res.
- 2022 Oct;20(4):506-508.
- doi: 10.5217/ir.2022.00003
-
- CITED
-
- Close
- SHARE
-
- Close
- Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements
-
Park YE, Lee YJ, Chang JY, Song HJ, Kim DH, Yang YJ, Kim BC, Lee JG, Yang HC, Choi M, Kim SE, Myung SJ
- KMID: 2535817
- Intest Res.
- 2022 Oct;20(4):431-444.
- doi: 10.5217/ir.2021.00111
Many unexpected problems have resulted from the unprecedented coronavirus disease 2019 (COVID-19) pandemic. The optimal management of patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic has also been... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study
-
Usami M, Takeuchi I, Kyodo R, Hirano Y, Kashiwagi K, Fujikawa H, Shimizu H, Kawai T, Arai K
- KMID: 2535821
- Intest Res.
- 2022 Oct;20(4):475-481.
- doi: 10.5217/ir.2021.00142
Background/Aims: Very early-onset inflammatory bowel disease (VEO-IBD), defined as IBD diagnosed in patients younger than 6 years, is a challenge for pediatric gastroenterologists. Although there have been reports regarding VEO-IBD... -
- CITED
-
- Close
- SHARE
-
- Close
- Natural history of inflammatory bowel disease: a comparison between the East and the West
-
Song EM, Yang SK
- KMID: 2535816
- Intest Res.
- 2022 Oct;20(4):418-430.
- doi: 10.5217/ir.2021.00104
Over the past decades, there has been a rapid increase in the incidence and prevalence of inflammatory bowel disease (IBD) in Asia. The natural history of IBD in Asian patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of hepatitis B vaccination in patients with ulcerative colitis: a prospective cohort study
-
Mishra A, Puri AS, Sachdeva S, Dalal A
- KMID: 2535818
- Intest Res.
- 2022 Oct;20(4):445-451.
- doi: 10.5217/ir.2021.00106
Background/Aims: Response to vaccine in patients with inflammatory bowel disease is lower than in the general population. We aimed to evaluate the efficacy of hepatitis B virus (HBV) vaccination in... -
- CITED
-
- Close
- SHARE
-
- Close
- Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis?
-
Mantaka A, Galanakis N, Tsetis D, Koutroubakis IE
- KMID: 2535823
- Intest Res.
- 2022 Oct;20(4):495-505.
- doi: 10.5217/ir.2022.00017
Background/Aims: Abdominal aortic calcium (AAC) deposition has been suggested as a marker of early atherosclerosis. There is no published data on the evaluation of AAC in inflammatory bowel disease (IBD). Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
-
Otake H, Matsumoto S, Mashima H
- KMID: 2535820
- Intest Res.
- 2022 Oct;20(4):464-474.
- doi: 10.5217/ir.2021.00139
Background/Aims: Although anti-tumor necrosis factor (TNF)-α agents are important therapeutic drugs for Crohn’s disease (CD), data regarding their long-term sustained effects are limited. Herein, we evaluated the long-term loss of... -
- CITED
-
- Close
- SHARE
-
- Close
- Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis
-
Pae JY, Kim ES, Kim SK, Jung MK, Heo J, Lee JH, Park MA
- KMID: 2535822
- Intest Res.
- 2022 Oct;20(4):482-494.
- doi: 10.5217/ir.2021.00161
Background/Aims: Gastrointestinal bleeding (GIB) risk for non-vitamin K antagonist oral anticoagulants (NOACs) compared with warfarin is largely unknown. We aimed to determine the risk of overall and post-polypectomy GIB for... -
- CITED
-
- Close
- SHARE
-
- Close
- Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
-
Park Y, Choi CH, Kim HS, Moon HS, Kim DH, Kim JJ, Teng D, Park DI
- KMID: 2535819
- Intest Res.
- 2022 Oct;20(4):452-463.
- doi: 10.5217/ir.2021.00125
Background/Aims: Epidemiological data on steroid use in South Korean patients with inflammatory bowel disease (IBD) are limited. We documented the steroid use patterns in these patients, and whether physician education... -
- CITED
-
- Close
- SHARE
-
- Close
